Articles

The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.

Case Studies

Explore how Herspiegel's expertise led a groundbreaking connected device launch in healthcare. Dive into our digital and business insights.
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.

White Papers

In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.

All Resources

The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
Explore how Herspiegel's expertise led a groundbreaking connected device launch in healthcare. Dive into our digital and business insights.
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.